Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis via dual blockade of VEGFR2 and MET in osteosarcoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis via dual blockade of VEGFR2 and MET in osteosarcoma

Published:2019-02-15 Issue:4 Volume:145 Page:979-993
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Wang Gangyang¹²^ORCID,Sun Mengxiong¹²,Jiang Yafei¹²,Zhang Tao¹²,Sun Wei¹²,Wang Hongsheng¹²^ORCID,Yin Fei¹²,Wang Zhuoying¹²,Sang Weilin¹²,Xu Jing¹²,Mao Min¹²,Zuo Dongqing¹²,Zhou Zifei¹²,Wang Chongren¹²,Fu Zeze¹²,Wang Zongyi¹²^ORCID,Duan Zhenfeng³^ORCID,Hua Yingqi¹²,Cai Zhengdong¹²

Affiliation:

1. Department of Orthopaedics, Shanghai General HospitalShanghai Jiao Tong University School of Medicine Shanghai China

2. Shanghai Bone Tumor Institute Shanghai China

3. Department of OrthopaedicsDavid Geffen School of Medicine at UCLA Los Angeles CA

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32180

Reference49 articles.

1. International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons

2. Arsenic sulfide induces apoptosis and autophagy through the activation of ROS/JNK and suppression of Akt/mTOR signaling pathways in osteosarcoma

3. HDAC2 depletion promotes osteosarcoma’s stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy

4. Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?

5. Mifamurtide for the treatment of nonmetastatic osteosarcoma

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of the efficacy and safety of anlotinib for the treatment of recurrent epithelial ovarian cancer;Discover Oncology;2024-08-29

2. Combination of Sintilimab and Anlotinib for Metastatic Osteosarcoma: A Case Report;OncoTargets and Therapy;2024-08

3. Anlotinib destabilizes PAX3-FOXO1 to induce rhabdomyosarcoma cell death via upregulating NEK2;Biomedicine & Pharmacotherapy;2024-08

4. Whole-Exome Sequencing Identifies Germline BLM Mutation in Ovarian Hepatoid Adenocarcinoma with Favorable Response to Niraparib and Anlotinib Combination Therapy—A Case Report and Literature Review;International Journal of Surgical Pathology;2024-07-25

5. Thymic carcinoid with multiple bone metastases: A case report;World Journal of Clinical Cases;2024-05-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3